195
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Non-compliance and inertia in hypertensive Spaniards at high cardiovascular risk: CUMPLE study

, , , , , , , , , , , , & show all
Pages 11-17 | Accepted 24 Sep 2013, Published online: 17 Oct 2013

References

  • Márquez-Contreras E, Martell-Claros N, Gil-Guillén V, et al; Compliance Group of the Spanish Society of Hypertension (SEE). Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens 2006;24:169-75
  • Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
  • Hughes D. When drugs don’t work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. Pharmacoeconomics 2007;25:621-35
  • Márquez Contreras E, Gil Guillén V, Martell Claros N, et al. Análisis de los estudios publicados sobre el incumplimiento terapéutico en el tratamiento de la HTA en España, entre los años 1984 y 2005. Aten Primaria 2006;38:325-32
  • Llisterri Caro JL, Rodríguez Roca GC, Alonso Moreno FJ, et al. Evolución del control de la presión arterial en España en el período 2002–2006. Estudios PRESCAP. Hipertensión 2009;26:257-65
  • Márquez Contreras E, Vegazo García O, Martell Claros N, et al. Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUM–HTA study. Blood Press 2005;14:151-8
  • Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825-34
  • Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52
  • Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007;167:141-7. Erratum in: Arch Intern Med 2007;167:648
  • Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009;18:308-47
  • [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks]. Praxis (Bern 1994). 2004 Oct 27;93:1836
  • Julius S, Weber MA, Kjeldsen SE, et al. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension 2006;48:385-91
  • Mancia G, De Backer G, Dominiczak A, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87. Erratum in: J Hypertens 2007;25:1749
  • Cushman WC, Ford CE, Cutler JA, et al; ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-404
  • Gil Guillén VF, Orozco Beltrán D, Quirce Andrés F, et al. Aplicación práctica de la estadística. In: Tratado de epidemiología clínica. 2nd Department of Medicine and Psychiatry. University of Alicante. Madrid: Cyma Duphont-Pharma, 1995:101-58
  • Armario P, Waeber B. Therapeutic strategies to improve control of hypertension. J Hypertens 2013;31(Suppl 1):S9-12
  • Márquez Contreras E, Martell Claros N, Gil Guillén V, et al. Intervención no farmacológica como estrategia para favorecer el control de la HTA y mejorar el cumplimiento antihipertensivo. Aten Primaria 2009;41:501-10
  • Van Onzenoort HA, Verberk WJ, Kroon AA, et al. Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension. J Hypertens 2010;28:622-7
  • Gil VF, Puras A, Suárez E, et al. Influencia del incumplimiento terapéutico en los pacientes con hipertensión esencial no controlados con monoterapia. Med Clin 2001;116:109-13
  • Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006;47:345-51
  • Phillips LS, Twombly JG. It’s time to overcome clinical inertia. Ann Intern Med 2008;148:783-5
  • Redón J, Coca A, Lázaro P, et al. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens 2010;28:1770-7
  • Gil-Guillén V, Orozco-Beltrán D, Pérez RP, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press 2010;19:3-10
  • Perreault S, Yu AY, Côté R, et al. Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology 2012;79:2037-43
  • Ferrari P, Hess L, Pechere-Bertschi A, et al. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens 2004;22:1221-9
  • Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002;162:413-20
  • Sanfelix-Genovés J, Gil-Guillén VF, Orozco-Beltran D, et al. Determinant factors of osteoporosis patients’ reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. Drugs Aging 2009;26:861-9
  • Gil-Guillén V, Orozco-Beltrán D, Carratalá-Munuera C, et al. Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment. Am J Cardiovasc Drugs 2013;13:213-19
  • O'Connor PJ, Sperl-Hillen JAM, Johnson PE, et al. Clinical inertia and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb
  • Márquez-Contreras E, de la Figuera-Von Wichmann M, Franch-Nadal J, et al. Do patients with high vascular risk take antihypertensive medication correctly? Cumple-MEMS Study. Rev Esp Cardiol (Engl Ed) 2012;65:544-50
  • Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-64
  • Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008 Apr 16;(2):CD000011
  • Merino J, Gil V, Cañizares R. Métodos de medida del cumplimiento aplicado a las enfermedades cardiovasculares. Gil VF (ed.) Cumplimiento terapéutico. Med Clin (Bar) 2001;116(Suppl 2):38-45
  • Márquez-Contreras E, Coca A, de la Figuera von Wichmann M, et al; Control-Project Researchers. [Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study] [in Spanish]. Med Clin (Barc) 2007;128:86-91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.